Zhe Xing-wei, Gao Fei, Nie Hong-gang, Tian Xin-kui, Chen Wei, Liu Hu-wei, Lindholm Bengt, Axelsson Jonas, Wang Tao
Division of Nephrology, Peking University Third Hospital, Beijing, China.
Am J Nephrol. 2008;28(6):1007-13. doi: 10.1159/000148208. Epub 2008 Jul 23.
High peritoneal transport status in end-stage renal disease patients receiving peritoneal dialysis was shown to be associated with increased morbidity and mortality. Although the pathogenesis of increased peritoneal transport is still not clear, previous studies have demonstrated that phospholipids (PLs) are present on the peritoneal mesothelium and when added to dialysate can decrease the peritoneal fluid absorption rate and increase peritoneal fluid removal. In the present report, we explored the relationship between peritoneal transport and dialysate loss of endogenous PLs.
We evaluated 48 prevalent continuous ambulatory peritoneal dialysis patients with high or low peritoneal transport in a cross-sectional study. The 4-hour dwell dialysate PL profile was analyzed by high-performance liquid chromatography coupled with electrospray ionization ion trap mass spectrometry. The patients' peritoneal small solute transport rate was assessed by D/P(Cr) at 4 h and their fluid transport by kinetic modeling.
While there were no significant differences between the 2 groups in age, sex, diabetic status and time on dialysis, high transporters had a significantly higher D/P(Cr) and peritoneal fluid absorption rate (K(e)) than low transporters. The PLs in dialysate effluents mainly consisted of PLs containing unsaturated fatty acid, and the concentrations, as well as the amount, of PLs were significantly elevated in the dialysate of high transporters as compared to low transporters.
Our results showed that dialysate from high transporters exhibited elevated levels of PLs, especially PLs containing unsaturated fatty acid, suggesting a possible loss of peritoneal surface-active PLs in peritoneal dialysis, and this loss may contribute to the alteration in peritoneal transport.
接受腹膜透析的终末期肾病患者的高腹膜转运状态与发病率和死亡率增加相关。尽管腹膜转运增加的发病机制仍不清楚,但先前的研究表明,磷脂(PLs)存在于腹膜间皮上,添加到透析液中可降低腹膜液吸收率并增加腹膜液清除率。在本报告中,我们探讨了腹膜转运与内源性PLs透析液损失之间的关系。
在一项横断面研究中,我们评估了48例高或低腹膜转运的持续性非卧床腹膜透析患者。通过高效液相色谱-电喷雾电离离子阱质谱联用分析4小时留腹透析液的PL谱。通过4小时的D/P(Cr)评估患者的腹膜小分子溶质转运率,并通过动力学模型评估其液体转运。
虽然两组在年龄、性别、糖尿病状态和透析时间方面无显著差异,但高转运者的D/P(Cr)和腹膜液吸收率(K(e))显著高于低转运者。透析液流出物中的PLs主要由含不饱和脂肪酸的PLs组成,与低转运者相比,高转运者的透析液中PLs的浓度和含量均显著升高。
我们的结果表明,高转运者的透析液中PLs水平升高,尤其是含不饱和脂肪酸的PLs,提示腹膜透析中腹膜表面活性PLs可能损失,这种损失可能导致腹膜转运改变。